A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
D000230:Adenocarcinoma / Q000378:metabolism*; D004338:Drug Combinations; D004341:Drug Evaluation; D017341:Etanidazole; D006801:Humans; D008545:Melanoma / Q000378:metabolism*; D009593:Nitroimidazoles / Q000097:blood / Q000378:metabolism*; D011838:Radiation-Sensitizing Agents / Q000097:blood / Q000378:metabolism*
D004338:Drug Combinations; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D017341:Etanidazole; C033815:pimonidazole